Circulating Biomarkers Determining Inflammation in Atherosclerosis Progression
Gerasimos Siasos(Brigham and Women's Hospital), Dimitris Tousoulis(National and Kapodistrian University of Athens), John Boletis(National and Kapodistrian University of Athens), Μaria Anastasiou(National and Kapodistrian University of Athens), Konstantinos Mourouzis, Konstantinos Vlasis, Evangelos Oikonomou(National and Kapodistrian University of Athens), Athanasios G. Papavassiliou(National and Kapodistrian University of Athens), Vicky Tsigkou, Maria Limperi, Marina Zaromitidou, Manolis Vavuranakis(National and Kapodistrian University of Athens), Vasiliki Gennimata(National and Kapodistrian University of Athens), Sotiris Tsalamandris
Cited by 12
Related Papers
Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
|Annals of the Rheumatic Diseases|2012|1k
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
|Annals of the Rheumatic Diseases|2023|913
European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-Year Follow-Up Outcomes and Differences Across Regions
|European Journal of Heart Failure|2016|781
Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
|Kidney International|2019|435
Empagliflozin Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) in High Fat Diet Fed ApoE(-/-) Mice by Activating Autophagy and Reducing ER Stress and Apoptosis
|International Journal of Molecular Sciences|2021|294